GSK Consumer Healthcare the maker of Advil, today announced its commitment to reducing the plastic in over 80 million Advil bottles1 by 20%, which will result in a reduction of nearly 500,000 pounds of plastic in the environment. By 2022, Advil will have reduced the plastic in nearly all bottles available in stores and online.
The initiative is a first-of-its-kind sustainable plastic technology for over-the-counter (OTC) medicines. This new barrier resin technology reduces the amount of resin required to mold and craft the bottles, while maintaining the same barrier protection properties. It allows for a 20% reduction in material usage for high-density polyethylene (HDPE) bottles that will never enter the environmental waste stream, without a reduction to critical performance characteristics of the bottle.
The new sustainability goal set by Advil is part of GSK‘s ambition for all consumer product packaging to be recyclable or reusable, including eliminating all problematic and unnecessary plastics when permitted, while ensuring the quality, safety and efficacy of our products, by 2025.